Compounding and the FDA: Questions & Answers
The Growing Popularity of GLP-1 Receptor Agonists: More Than Just Weight Loss The Growing Popularity of GLP-1 Receptor Agonists: More Than Just Weight Loss A class of medications known as GLP-1 receptor agonists, including popular brands like Ozempic and Wegovy, has surged in demand among individuals looking to lose weight
Ginhoux F, Guilliams M
Well replace or refund if an item arrives damaged, defective, or incorrect (contact us within 7 days of delivery with photos and your order number)
Heres what you need to know: Manufacturer Savings Programs Novo Nordisk (makes Wegovy, Ozempic, and Saxenda) offers savings cards that can reduce copays to as low as $25 per month for eligible patients with commercial insurance These programs have specific eligibility requirements and typically exclude Medicare/Medicaid patients Your doctors office can help you determine eligibility and apply Prior Authorization Tips If your insurance requires prior authorization, be patient
CMS is launching a program called the Medicare GLP-1 Bridge which gives eligible beneficiaries access to GLP-1 drugs for a $50 monthly copay
